A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model

Pain
Pamela S PuttfarckenRegina M Reilly

Abstract

The TRPV1 antagonist A-995662 demonstrates analgesic efficacy in monoiodoacetate-induced osteoarthritic (OA) pain in rat, and repeated dosing results in increased in vivo potency and a prolonged duration of action. To identify possible mechanism(s) underlying these observations, release of neuropeptides and the neurotransmitter glutamate from isolated spinal cord was measured. In OA rats, basal release of glutamate, bradykinin and calcitonin gene-related peptide (CGRP) was significantly elevated compared to naïve levels, whereas substance P (SP) levels were not changed. In vitro studies showed that capsaicin-evoked TRPV1-dependent CGRP release was 54.7+/-7.7% higher in OA, relative to levels measured for naïve rats, suggesting that TRPV1 activity was higher under OA conditions. The efficacy of A-995662 in OA corresponded with its ability to inhibit glutamate and CGRP release from the spinal cord. A single, fully efficacious dose of A-995662, 100 micromol/kg, reduced spinal glutamate and CGRP release, while a single sub-efficacious dose of A-995662 (25 micromol/kg) was ineffective. Multiple dosing with A-995662 increased the potency and duration of efficacy in OA rats. Changes in efficacy did not correlate with plasma concentrat...Continue Reading

References

Apr 3, 2001·Annual Review of Neuroscience·M J Caterina, D Julius
Jun 19, 2001·American Journal of Physiology. Heart and Circulatory Physiology·M CyrA Adam
Nov 8, 2001·European Journal of Pharmacology·R CoutureF Cloutier
Jul 13, 2002·Annals of the New York Academy of Sciences·Hans-Georg SchaibleGisela Segond Von Banchet
Jul 20, 2002·Current Rheumatology Reports·Thomas Graven-Nielsen, Lars Arendt-Nielsen
Sep 2, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Haibin WangClifford J Woolf
Sep 15, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·M CuiC R Faltynek
Nov 8, 2006·Handbook of Experimental Pharmacology·R G Hill, K R Oliver
Jul 25, 2007·Progress in Brain Research·Fred Nyberg, Mathias Hallberg
Nov 18, 2008·Journal of Neurochemistry·Hong-Yi ZhouHui-Lin Pan
Dec 10, 2008·Expert Opinion on Therapeutic Targets·Lisa M BroadDavid Bleakman
Dec 10, 2008·Drug Discovery Today·Martin J Gunthorpe, Boris A Chizh
Mar 24, 2009·Current Neuropharmacology·Louis S Premkumar, Parul Sikand
Apr 21, 2009·European Journal of Pharmacology·Prasant ChandranPrisca Honore
Apr 28, 2009·Experimental Brain Research·Kazue MizumuraYasuko Kozaki
Aug 14, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yong Ho KimSeog Bae Oh
Jun 24, 2010·Bioorganic & Medicinal Chemistry·Richard J PernerMichael E Kort

❮ Previous
Next ❯

Citations

Jul 17, 2012·Journal of Molecular Neuroscience : MN·Ping HanConnie R Faltynek
Apr 4, 2013·Menopause : the Journal of the North American Menopause Society·Xin-Feng ZhengLei-Sheng Jiang
May 28, 2011·Annals of the Rheumatic Diseases·Ana M ValdesMichael Doherty
Jan 26, 2016·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Youngkyung KimYoung Wook Yooon
Mar 13, 2016·Osteoarthritis and Cartilage·Ken KodaYasuhide Morioka
Apr 30, 2015·British Journal of Clinical Pharmacology·David A WalshSara Kelly
Sep 28, 2012·Phytotherapy Research : PTR·Catherine E FerlandPascal Vachon
Oct 16, 2012·British Journal of Pharmacology·A J MoggL M Broad
Oct 10, 2013·British Journal of Pharmacology·Yosuke Kaneko, Arpad Szallasi
Nov 8, 2014·Journal of Veterinary Pharmacology and Therapeutics·S NiyomM L Rezende
Aug 27, 2013·Osteoarthritis and Cartilage·R-X ZhangR Dubner
Jun 10, 2011·Neuroscience Letters·Guy CalcottIstvan Nagy
Dec 16, 2016·Medicinal Research Reviews·Mojgan Aghazadeh TabriziPier Andrea Borea
Dec 17, 2016·Pharmaceuticals·Michael J Caterina, Zixuan Pang
Jan 1, 2011·Pharmaceuticals·Asia Fernández-CarvajalAntonio Ferrer-Montiel
Jan 1, 2012·Pharmaceuticals·Michael R BrandtStephen M Stahl
Apr 24, 2019·International Journal of Molecular Sciences·Zong-Sheng WuShu-Hung Huang
Jan 3, 2014·Physiological Reviews·Emmanuel BourinetGerald W Zamponi
Oct 8, 2014·Physiological Reviews·F A RussellS D Brain
Oct 18, 2019·Frontiers in Pharmacology·João de Sousa Valente
Nov 23, 2017·Frontiers in Molecular Neuroscience·Annett EitnerHans-Georg Schaible
Nov 10, 2020·Drugs·Mircea IftincaChristophe Altier
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Seyeon OhKyunghee Byun
Jun 29, 2021·Current Treatment Options in Rheumatology·Alia M ObeidatRachel E Miller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.